Showing results 1 to 20 of 50
next >
| Issue Date | Title | Author(s) |
| 2023-03-29 | A Method for Rapid, Quantitative Evaluation of Particle Sorting in Microfluidics Using Basic Cytometry Equipment. | Salomon, R; Razavi Bazaz, S; Li, W; Gallego-Ortega, D; Jin, D; Warkiani, ME |
| 2017-11 | A mutation in the viral sensor 2'-5'-oligoadenylate synthetase 2 causes failure of lactation. | Oakes, SR; Gallego-Ortega, D; Stanford, PM; Junankar, S; Au, WWY; Kikhtyak, Z; von Korff, A; Sergio, CM; Law, AMK; Castillo, LE; Allerdice, SL; Young, AIJ; Piggin, C; Whittle, B; Bertram, E; Naylor, MJ; Roden, DL; Donovan, J; Korennykh, A; Goodnow, CC; O'Bryan, MK; Ormandy, CJ |
| 2017-10-03 | A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts. | Nobis, M; Herrmann, D; Warren, SC; Kadir, S; Leung, W; Killen, M; Magenau, A; Stevenson, D; Lucas, MC; Reischmann, N; Vennin, C; Conway, JRW; Boulghourjian, A; Zaratzian, A; Law, AM; Gallego-Ortega, D; Ormandy, CJ; Walters, SN; Grey, ST; Bailey, J; Chtanova, T; Quinn, JMW; Baldock, PA; Croucher, PI; Schwarz, JP; Mrowinska, A; Zhang, L; Herzog, H; Masedunskas, A; Hardeman, EC; Gunning, PW; Del Monte-Nieto, G; Harvey, RP; Samuel, MS; Pajic, M; McGhee, EJ; Johnsson, A-KE; Sansom, OJ; Welch, HCE; Morton, JP; Strathdee, D; Anderson, KI; Timpson, P |
| 2017-11-07 | Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer. | Valdés-Mora, F; Gould, CM; Colino-Sanguino, Y; Qu, W; Song, JZ; Taylor, KM; Buske, FA; Statham, AL; Nair, SS; Armstrong, NJ; Kench, JG; Lee, KML; Horvath, LG; Qiu, M; Ilinykh, A; Yeo-Teh, NS; Gallego-Ortega, D; Stirzaker, C; Clark, SJ |
| 2022-05-03 | Activation of the viral sensor oligoadenylate synthetase 2 (Oas2) prevents pregnancy-driven mammary cancer metastases. | Ho, W-HJ; Law, AMK; Masle-Farquhar, E; Castillo, LE; Mawson, A; O'Bryan, MK; Goodnow, CC; Gallego-Ortega, D; Oakes, SR; Ormandy, CJ |
| 2021 | Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies. | Law, AMK; Rodriguez de la Fuente, L; Grundy, TJ; Fang, G; Valdes-Mora, F; Gallego-Ortega, D |
| 2022-07 | ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo. | Law, AMK; Chen, J; Colino-Sanguino, Y; Fuente, LRDL; Fang, G; Grimes, SM; Lu, H; Huang, RJ; Boyle, ST; Venhuizen, J; Castillo, L; Tavakoli, J; Skhinas, JN; Millar, EKA; Beretov, J; Rossello, FJ; Tipper, JL; Ormandy, CJ; Samuel, MS; Cox, TR; Martelotto, L; Jin, D; Valdes-Mora, F; Ji, HP; Gallego-Ortega, D |
| 2017-11-16 | Andy's Algorithms: new automated digital image analysis pipelines for FIJI. | Law, AMK; Yin, JXM; Castillo, L; Young, AIJ; Piggin, C; Rogers, S; Caldon, CE; Burgess, A; Millar, EKA; O'Toole, SA; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR |
| 2022-06 | Author Correction: Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote TH2 and inhibit TH17 cell polarization. | Mayer, JU; Hilligan, KL; Chandler, JS; Eccles, DA; Old, SI; Domingues, RG; Yang, J; Webb, GR; Munoz-Erazo, L; Hyde, EJ; Wakelin, KA; Tang, S-C; Chappell, SC; von Daake, S; Brombacher, F; Mackay, CR; Sher, A; Tussiwand, R; Connor, LM; Gallego-Ortega, D; Jankovic, D; Le Gros, G; Hepworth, MR; Lamiable, O; Ronchese, F |
| 2013-09 | BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer. | Stone, A; Cowley, MJ; Valdes-Mora, F; McCloy, RA; Sergio, CM; Gallego-Ortega, D; Caldon, CE; Ormandy, CJ; Biankin, AV; Gee, JMW; Nicholson, RI; Print, CG; Clark, SJ; Musgrove, EA |
| 2020-05 | Capillary-assisted microfluidic biosensing platform captures single cell secretion dynamics in nanoliter compartments. | Hassanzadeh-Barforoushi, A; Warkiani, ME; Gallego-Ortega, D; Liu, G; Barber, T |
| 2017-04-18 | Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer. | Valdés-Mora, F; Locke, WJ; Bandrés, E; Gallego-Ortega, D; Cejas, P; García-Cabezas, MA; Colino-Sanguino, Y; Feliú, J; Del Pulgar, TG; Lacal, JC |
| 2019-01-01 | Droplet-based single cell RNAseq tools: A practical guide | Salomon, R; Kaczorowski, D; Valdes-Mora, F; Nordon, RE; Neild, A; Farbehi, N; Bartonicek, N; Gallego-Ortega, D |
| 2015-12 | ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells. | Gallego-Ortega, D; Ledger, A; Roden, DL; Law, AMK; Magenau, A; Kikhtyak, Z; Cho, C; Allerdice, SL; Lee, HJ; Valdes-Mora, F; Herrmann, D; Salomon, R; Young, AIJ; Lee, BY; Sergio, CM; Kaplan, W; Piggin, C; Conway, JRW; Rabinovich, B; Millar, EKA; Oakes, SR; Chtanova, T; Swarbrick, A; Naylor, MJ; O'Toole, S; Green, AR; Timpson, P; Gee, JMW; Ellis, IO; Clark, SJ; Ormandy, CJ |
| 2016-01-07 | ELF5 isoform expression is tissue-specific and significantly altered in cancer. | Piggin, CL; Roden, DL; Gallego-Ortega, D; Lee, HJ; Oakes, SR; Ormandy, CJ |
| 2013-11 | ELF5, normal mammary development and the heterogeneous phenotypes of breast cancer | Gallego-Ortega, D; Oakes, SR; Lee, HJ; Piggin, CL; Ormandy, CJ |
| 2013-05-23 | Functional characterization of cancer-associated Gab1 mutations. | Ortiz-Padilla, C; Gallego-Ortega, D; Browne, BC; Hochgräfe, F; Caldon, CE; Lyons, RJ; Croucher, DR; Rickwood, D; Ormandy, CJ; Brummer, T; Daly, RJ |
| 2020-10 | Genomic Cytometry and New Modalities for Deep Single-Cell Interrogation. | Salomon, R; Martelotto, L; Valdes-Mora, F; Gallego-Ortega, D |
| 2020-10 | Genomic Cytometry Editorial. | Salomon, R; Gallego-Ortega, D |
| 2019-12 | Gradient-sized control of tumor spheroids on a single chip. | Fang, G; Lu, H; Law, A; Gallego-Ortega, D; Jin, D; Lin, G |
